Oldest Man in U.S. Dies at 110 After Walking Daily and Avoiding Bottled Water — Now Scientists Will Study His Brain (Exclusive story from People Magazine)

Dr. Mark Carlson is featured in an interview on Alzheimer’s Disease. The interview was conducted by Cyndi Cummings, Austin-based expert advocate for seniors.

Can treating hearing loss improve the progression of cognitive function and reduce dementia risk?

While the nationwide "body positivity" movement empowers individuals and boosts confidence, it raises the question of whether we are inadvertently sacrificing our health. Are we justifying obesity?

In a significant stride for global health, the U.S. Food and Drug Administration (FDA) has given its approval to the first-ever vaccine for Respiratory Syncytial Virus (RSV).

New therapies are on the horizon and the future for both treatment and prevention of Alzheimer’s disease looks promising.

One of the key advantages of monoclonal mRNA vaccines is their speed and flexibility. Because they can be designed and produced in a laboratory setting, they can be developed much more quickly than traditional vaccines. This has been demonstrated in the rapid development of mRNA vaccines for COVID-19, with the Pfizer-BioNTech and Moderna vaccines receiving emergency use authorization from the FDA in less than a year from the start of the pandemic.

Dr. Carlson was invited by Civitas Senior Living to share his insights about the influences of technology on senior health. His focus on this important aspect of aging is helping to shape the way he delivers medical care to his patients.

Millions suffer from chronic pain. In our practice, this is a common topic of conversation with patients. Thanks to the latest research in therapy options, the FDA has recently approved a new spinal cord stimulation system for the treatment of chronic pain.

A cell phone app that combines white noise, active game-based therapy, and counseling could help “rewire” the brain to provide relief from tinnitus symptoms, new research suggests.

RSV causes a respiratory tract infection that affects 64 million people per year worldwide. It hospitalizes 3 million children under 5 years old and approximately 336,000 older adults annually (Lancet 2020). After decades of research, hope is on the horizon for a vaccine to prevent this devastating disease. Join Dr. Carlson for a conversation about RSV, this deadly virus. What causes RSV? What are the treatment options? How far out are we from a vaccine to make RSV a preventable disease?

I imagine there is a different answer with every person who is asked. And I’m sure each answer would be as true as the last. Incredible inventions have changed our lives and continue to do so. As a medical provider I have witnessed some awesome medical inventions that have saved and improved lives.

Ever wonder how your medicine makes it to the pharmacy? The Covid-19 pandemic has given us a glimpse into the world of drug development. It’s a fascinating process and has been perfected over time to ensure that the medicine we take every day to ease our pain and keep us functioning is safe. This blog shares with you the 5 steps in the drug development process in the US.

I apologize for the glib title. There is no doubt, this pandemic has been devastating. However, trying to find the good in something bad is my intent. Allow me to list some of the silver linings to this dark cloud that we hope to see clearing soon.

Meningococcal disease is a devastating infection, a key cause of meningitis, sepsis, and, less often, pneumonia, pericarditis, and septic arthritis. Neisseria meningitidis (the bacteria that causes the disease) tends to strike young, otherwise well individuals and can progress to death in a matter of hours.